<PAGE> 1
================================================================================
U.S. SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-QSB
(MARK ONE)
[X] QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE
ACT OF 1934
For the quarterly period ended May 31, 1999
{ ] TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES
EXCHANGE ACT OF 1934
For the transition period from _____________ to ____________
COMMISSION FILE NUMBER 0-20866
WILSHIRE TECHNOLOGIES, INC.
(Exact name of small business issuer as specified in its charter)
<TABLE>
<S> <C>
CALIFORNIA 33-0433823
(State or other jurisdiction of incorporation or organization) (I.R.S. Employer Identification No.)
</TABLE>
5861 EDISON PLACE
CARLSBAD, CALIFORNIA 92008
(Address of principal executive offices)
(760) 929-7200
(Issuer's telephone number)
Check whether the issuer (1) filed all reports required to be filed by
Section 13 or 15(d) of the Exchange Act during the past 12 months (or for such
shorter period that the registrant was required to file such reports), and (2)
has been subject to such filing requirements for the past 90 days.
Yes [X] No [ ]
The number of shares outstanding of the registrant's only class of
Common Stock, no par value, was 12,953,385 on JULY 12, 1999.
Transitional Small Business Disclosure Format. Yes [ ] No [X]
================================================================================
<PAGE> 2
WILSHIRE TECHNOLOGIES, INC.
INDEX TO FORM 10-QSB
<TABLE>
<CAPTION>
- ------------------------------------------------------------------------------------
PART 1 - FINANCIAL INFORMATION PAGE
- ------------------------------------------------------------------------------------
<S> <C>
Item 1. Financial Statements:
Condensed Consolidated Balance Sheets as of 3
May 31, 1999 and November 30, 1998
Condensed Consolidated Statements of Operations 4
for the Three Months Ended May 31, 1999 and
May 31, 1998
Condensed Consolidated Statements of Operations 5
for the Six Months Ended May 31, 1999 and
May 31, 1998
Condensed Consolidated Statements of Cash Flows 6
for the Six Months Ended May 31, 1999 and
May 31, 1998
Notes to Condensed Consolidated Financial Statements 7
Item 2. Management's Discussion and Analysis 9
or Plan of Operation
- ------------------------------------------------------------------------------------
PART II - OTHER INFORMATION
- ------------------------------------------------------------------------------------
Item 1. Legal Proceedings 12
Item 2. Changes in Securities 12
Item 3. Defaults Upon Senior Securities 12
Item 4. Submission of Matters to a Vote of Security Holders 12
Item 5. Other Information 12
Item 6. Exhibits and Reports on Form 8-K 13
Signatures 13
</TABLE>
<PAGE> 3
WILSHIRE TECHNOLOGIES, INC.
CONDENSED CONSOLIDATED BALANCE SHEETS
<TABLE>
<CAPTION>
May 31, November 30,
1999 1998
------------ ------------
(Unaudited) (Note)
<S> <C> <C>
ASSETS
Current assets:
Cash $ 115,000 $ 42,000
Accounts receivable trade, less allowance for doubtful
accounts of $7,000 at May 31, 1999
and $5,000 at November 30, 1998, respectively 335,000 310,000
Inventories (Note 2) 1,412,000 1,228,000
Note receivable 32,000 127,000
Other current assets 307,000 246,000
------------ ------------
Total current assets 2,201,000 1,953,000
Property and equipment, less accumulated depreciation 3,690,000 3,565,000
Goodwill, less accumulated amortization of $386,000
and $365,000 at May 31, 1999 and November 30,
1998, respectively 356,000 377,000
Patents and trademarks, net 119,000 116,000
------------ ------------
$ 6,366,000 $ 6,011,000
============ ============
LIABILITIES AND SHAREHOLDERS' EQUITY (NET CAPITAL DEFICIENCY)
Current liabilities:
Accounts payable $ 262,000 $ 412,000
Accrued expenses 527,000 416,000
Interest payable 1,114,000 578,000
Line of credit (Note 3) 10,183,000 8,407,000
------------ ------------
Total current liabilities 12,086,000 9,813,000
Shareholders' equity (net capital deficiency)
Preferred stock, no par value, 2,000,000 shares authorized
and none issued and outstanding -- --
Common stock, no par value, 50,000,000 shares
authorized; 12,953,385 shares and 12,943,385 shares
issued and outstanding at May 31, 1999 and
November 30, 1998, respectively 25,912,000 25,907,000
Common stock warrants 387,000 370,000
Accumulated deficit (32,019,000) (30,079,000)
------------ ------------
Total shareholders' equity (net capital deficiency) (5,720,000) (3,802,000)
------------ ------------
$ 6,366,000 $ 6,011,000
============ ============
</TABLE>
Note: The condensed consolidated balance sheet at November 30, 1998 has
been derived from the audited financial statements at that date but
does not include all of the information and footnotes required by
generally accepted accounting principles for complete financial
statements.
See accompanying notes.
3
<PAGE> 4
WILSHIRE TECHNOLOGIES, INC.
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(UNAUDITED)
<TABLE>
<CAPTION>
Three Months Ended May 31,
---------------------------------
1999 1998
--------------- ------------
<S> <C> <C>
Net sales $ 812,000 $ 1,032,000
Cost of sales 746,000 682,000
------------ ------------
Gross profit (loss) 66,000 350,000
Operating expenses:
Marketing and selling 149,000 117,000
General and administrative 396,000 435,000
Research and development 43,000 74,000
------------ ------------
Total operating expenses 588,000 626,000
------------ ------------
Loss from operations (522,000) (276,000)
Other income 3,000 --
Interest income (expense), net (288,000) (207,000)
------------ ------------
Loss before provision
for state income taxes (807,000) (483,000)
Provision for state income taxes - current -- --
------------ ------------
Net loss $ (807,000) $ (483,000)
============ ============
Weighted average shares basic and diluted 12,953,000 12,943,000
============ ============
Basic and diluted loss per share $ (0.06) $ (0.04)
============ ============
</TABLE>
See accompanying notes.
4
<PAGE> 5
WILSHIRE TECHNOLOGIES, INC.
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(UNAUDITED)
<TABLE>
<CAPTION>
Six Months Ended May 31,
---------------------------------
1999 1998
------------ ------------
<S> <C> <C>
Net sales $ 1,443,000 $ 2,085,000
Cost of sales 1,511,000 1,641,000
------------ ------------
Gross profit (loss) (68,000) 444,000
Operating expenses:
Marketing and selling 305,000 247,000
General and administrative 888,000 807,000
Research and development 108,000 148,000
------------ ------------
Total operating expenses 1,301,000 1,202,000
------------ ------------
Loss from operations (1,369,000) (758,000)
Other income 5,000 1,000
Interest income (expense), net (575,000) (329,000)
------------ ------------
Loss before provision
for state income taxes (1,939,000) (1,086,000)
Provision for state income taxes - current 1,000 1,000
------------ ------------
Net loss $ (1,940,000) $ (1,087,000)
============ ============
Weighted average shares basic and diluted 12,953,000 12,943,000
============ ============
Basic and diluted loss per share $ (0.15) $ (0.08)
============ ============
</TABLE>
See accompanying notes.
5
<PAGE> 6
WILSHIRE TECHNOLOGIES, INC.
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(UNAUDITED)
<TABLE>
<CAPTION>
Six Months Ended May 31,
-------------------------------
1999 1998
----------- -----------
<S> <C> <C>
OPERATING ACTIVITIES
Net loss $(1,940,000) $(1,087,000)
Adjustments to reconcile net loss to net cash
used in operating activities:
Depreciation and amortization 375,000 117,000
Provision for loss on accounts receivable 2,000 --
Net change in operating assets and liabilities:
(Increase) decrease in accounts receivable (27,000) (182,000)
Increase in inventories (184,000) (444,000)
Increase in other current assets (61,000) (17,000)
Increase (decrease) in accounts payable and
accrued expenses (39,000) (188,000)
Increase (decrease) in interest payable 536,000 (202,000)
----------- -----------
Net cash provided by (used in) operating activities (1,338,000) (2,003,000)
----------- -----------
INVESTING ACTIVITIES
Purchase of equipment (457,000) (1,380,000)
Decrease in note receivable 95,000 89,000
Increase in other assets (8,000) (8,000)
----------- -----------
Net cash used in investing activities (370,000) (1,299,000)
----------- -----------
FINANCING ACTIVITIES
Proceeds from line of credit 1,776,000 3,343,000
Warrants issued to majority shareholder -- 48,000
Exercise of Stock Options 5,000 --
Debt issue costs, net -- (113,000)
----------- -----------
Net cash provided by financing activities 1,781,000 3,278,000
----------- -----------
NET INCREASE (DECREASE) IN CASH 73,000 (24,000)
CASH - BEGINNING OF PERIOD 42,000 137,000
----------- -----------
CASH - END OF PERIOD $ 115,000 $ 113,000
=========== ===========
</TABLE>
See accompanying notes.
6
<PAGE> 7
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
1. ORGANIZATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
ORGANIZATION
Wilshire Technologies, Inc. (the "Company") develops, manufactures and markets
engineered polymer products for industrial clean room use. The Company, based in
Carlsbad, California, markets products through its Wilshire Contamination
Control Division, and manufactures certain of its products in its wholly-owned
Mexican subsidiary, Wilshire International de Mexico S.A. de C.V. During 1996,
the Company divested its Medical Products and Transdermal Products divisions and
has since focused primarily on products used in industrial clean rooms, such as
gloves and contamination control products.
BASIS OF PRESENTATION
The accompanying condensed consolidated unaudited financial statements have been
prepared in accordance with generally accepted accounting principles for interim
financial information and with the instructions to Form 10-QSB for quarterly
reports under Section 13 or 15(d) of the Securities Exchange Act of 1934.
Accordingly, they do not include all of the information and footnotes required
by generally accepted accounting principles for complete financial statements.
In the opinion of management, all adjustments (consisting of normal recurring
accruals) considered necessary for a fair presentation have been included.
Operating results for the quarter and six months ended May 31, 1999 are not
necessarily indicative of the results that may be expected for the fiscal year
ending November 30, 1999. For further information, refer to the financial
statements and footnotes thereto included in the Company's annual report on Form
10-KSB for the fiscal year ended November 30, 1998.
The consolidated financial statements include the accounts of the Company and
its wholly-owned subsidiary. Significant intercompany amounts and transactions
have been eliminated.
2. FINANCIAL STATEMENT INFORMATION
Inventories consist of the following:
<TABLE>
<CAPTION>
MAY 31, NOVEMBER 30,
1999 1998
---------- ----------
<S> <C> <C>
Raw materials $ 633,000 $ 604,000
Work in process 327,000 239,000
Finished goods 452,000 385,000
---------- ----------
$1,412,000 $1,228,000
========== ==========
</TABLE>
7
<PAGE> 8
3. LINE OF CREDIT
On January 5, 1996, the Company and Trilon Dominion entered into a Credit
Agreement (the "Agreement") for a credit line of $1,000,000 secured by the
Company's assets. Under the terms of the Agreement, the principal was due on
June 30, 1996 and the interest was payable monthly at a rate of prime plus
3.75%. In connection with the loan, the Company issued Trilon Dominion a
five-year warrant that entitles Trilon Dominion to purchase 100,000 shares of
the Company's authorized but unissued common stock at an exercise price of $0.75
per share, subject to adjustment to protect against dilution. The warrant is
exercisable immediately and expires on January 5, 2001. Also, under the terms of
the Agreement, the Company issued Trilon Dominion a second five-year warrant
which became exercisable when the Company and Trilon Dominion amended the
Agreement to extend the termination date of the Agreement to December 31, 1996.
The second warrant entitles Trilon Dominion to purchase 25,000 shares of the
Company's authorized but unissued common stock at an exercise price of $1.75 per
share and it expires on January 5, 2001. The holder of each of such five-year
warrants may, without payment to the Company, convert the warrant in whole or in
part into shares of the Company's common stock having a market value equal to
the difference between (x) the market value per share of common stock multiplied
by the number of warrants that are converted and (y) the warrant exercise price,
multiplied by the number of warrants that are converted.
The Agreement was amended further on September 30, 1996, April 15, 1997, and
September 19, 1997. Each amendment increased the credit line by $1,000,000, up
to a total of $4,000,000, and extended the termination date, to June 30, 1998.
Trilon Dominion received a warrant to purchase 100,000 shares at the market
price with each credit line increase, and a warrant to purchase 25,000 shares at
the market price with each termination date extension. Warrants for 225,000
shares were issued in each of fiscal years 1996 and 1997 and warrants for 50,000
shares were issued in fiscal year 1998. The Company recorded the estimated fair
value of the warrants issued in fiscal year 1997 and fiscal year 1998 at $0.07
per underlying common share with a corresponding charge to earnings of $16,000
in fiscal 1997 and $3,500 in fiscal year 1998.
On January 7, 1998, February 17, 1998 and March 10, 1998, the Company and Trilon
Dominion completed Demand Notes, each for $250,000 at an interest rate of
12.25%, to fund the Company's ongoing operations until a new credit facility
could be completed.
On March 31, 1998 the Company and Trilon Dominion completed an Amended and
Restated Credit Agreement and Revolving Line of Credit (the "Amended
Agreement":) which included the principal of $4,000,000 from the previous
Agreement and Amendments, the principal of $750,000 from the six Demand Notes,
the accrued interest and management fees of $543,297 on the Agreement and Notes,
and a new credit line commitment of $2,200,000. Under the terms of the Amended
Agreement, the principal of $7,493,297 was due on December 31, 1998, and the
interest is payable quarterly at an annual rate of 11.5%. In connection with the
Amendment Agreement, the Company paid Trilon $100,000 for debt issuance costs
and issued Trilon Dominion a five-year warrant that entitles Trilon Dominion to
purchase 650,000 shares of the Company's authorized but unissued common stock at
an exercise price of $0.41 per share, subject to adjustment to protect against
dilution. The warrant is exercisable immediately and expires on March 31, 2003.
The Company recorded the estimated fair value of the warrant to purchase 650,000
shares as a debt issuance cost in the second quarter of fiscal year 1998 at
$0.07 per underlying common share. On December 31, 1998, under the terms of the
Amended Agreement, the Company issued Trilon Dominion a second five-year warrant
which became
8
<PAGE> 9
exercisable when the Company and Trilon Dominion agreed to extend the due date
of the principal and interest from December 31, 1998 to January 31, 2000. The
second warrant entitles Trilon Dominion to purchase 250,000 shares of the
Company's authorized but unissued common stock at an exercise price of $0.42 per
underlying common share and expires on March 31, 2003. On December 31, 1998, the
Company recorded the estimated fair value of the warrants at $0.07 per
underlying common share with a corresponding charge to earnings of $17,500.
From August 1998 to June 1999, the Company and Trilon Dominion completed Demand
Notes totalling $2,940,000 at an interest rate of 11.5% to fund ongoing
operations. On July 5, 1999 the Company and Trilon Dominion completed a Demand
Note at the current market interest rate plus 2.5 % in the amount of $250,000.
4. COMMITMENTS AND CONTINGENCIES
BREAST IMPLANT LITIGATION
During the second six months of 1999, there have been no significant
developments in the Breast Implant Litigation. For information regarding legal
proceedings, refer to the information contained in the Company's Annual Report
on Form 10-KSB for the fiscal year ended November 30, 1998, under Note 6 to the
financial statements included therein.
ITEM 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OR PLAN OF OPERATION.
During the second quarter of 1999, the Company completed the start-up phase of
its new glove production line in the Company's leased plant facility in Tijuana,
Mexico and began production of the Company's DuraCLEAN(R) polyurethane gloves.
The Company also continued product improvement projects and expanded its
internal sales organization during the second quarter ended May 31, 1999.
From time to time the Company may report, through its press releases and/or
Securities and Exchange Commission filings, certain forward-looking statements
that are subject to risks and uncertainties. Important factors that could cause
actual results to differ materially from those projected by such forward-looking
statements are set forth in Exhibit 99 to the Company's Annual Report on Form
10-KSB for the fiscal year ended November 30, 1996. These include operating
losses, liquidity, reliance on major distributors, new product development,
competition, technological change, patents, trade secrets, product liability,
dependence on key suppliers, and dependence on key personnel.
9
<PAGE> 10
RESULTS OF OPERATIONS
NET SALES
The Company markets its products directly to end users through an internal sales
force utilizing outside distributors. Revenue for all sales is recognized when
title transfers, generally when products are shipped.
Net sales decreased by $220,000 (21.0%) to $812,000 in the second quarter of
1999 as compared to $1,032,000 in the second quarter of 1998. Net sales
decreased by $642,000 (31.0%) to $1,443,000 for the first six months of 1999 as
compared to $2,085,000 for the first six months of 1998. The decrease in sales
for the quarter and first six months was attributable to the loss of the
Company's largest consumer of UltraSORB(TM) wipers due to price erosion at the
end of the second quarter of fiscal year 1998. Consequently, the Company has
continuously focused on cost reduction programs to improve its price position in
the market.
GROSS PROFIT (DEFICIT)
For the second quarter ended May 31, 1999, the Company recorded a gross profit
of $66,000 as compared to gross profit of $350,000 for the same period of 1998.
For the first six months of 1999, the Company recognized a negative gross margin
of $68,000 as compared to a gross profit of $444,000 for the comparable period
in 1998. Although the Company has recognized profits on the sale of its
contamination control products, the decrease in gross profits was attributable
to the significant start-up costs associated with the new glove manufacturing
plant located in Tijuana, Mexico.
GENERAL AND ADMINISTRATIVE EXPENSES
General and administrative expenses include additional costs related to the
Company's marketing activities and administrative costs (such as executive and
office salaries, related payroll expenses, investor relations, professional
fees, supplies and utilities).
General and administrative expenses decreased $39,000 (9%) to $396,000 in the
second quarter of 1999 from $435,000 in the second quarter of 1998. The decease
was due primarily to higher legal fees incurred in the second quarter of the
prior year. In the first six months of 1999, General and Administrative expenses
increased by $81,000 (10%) to $888,000 from $807,000 for the first six months of
1998. The primary factors of the increase were additions in headcount in
executive management, and administrative costs associated with the start-up of
the glove's manufacturing operation in Tijuana, Mexico.
MARKETING AND SELLING EXPENSES
Marketing and selling expenses increased by $32,000 (27%) to $149,000 in the
second quarter of 1999 from $117,000 for the comparable period of 1998. The
first six months of expense increased by $58,000 (23%) to $305,000 from $247,000
for the first six months of 1998 . The quarter and year to date increase, as
compared to comparable periods in 1998, was primarily due to additional
personnel expenses, increased travel.
10
<PAGE> 11
RESEARCH AND DEVELOPMENT
Research and development expenses decreased $31,000 (42%) to $43,000 in the
second quarter of 1999 as compared to $74,000 in the second quarter of 1998. The
first six months of Research and development expense decreased by $40,000 (27%)
from expense of $148,000 for the same period of 1998. The decline was primarily
due to decreased project expenses.
INTEREST INCOME (EXPENSE), NET
The Company reported higher interest expense in the second quarter and for the
first six months of 1999 versus the same period of 1998 due to increased debt
outstanding. The interest expense was related primarily to the line of credit
due to Trilon Dominion Partners, LLC. (see Note 4).
INCOME TAXES
For the quarters ended May 31, 1999 and May 31, 1998, the Company sustained
losses for both financial reporting and income tax purposes. A tax provision of
$1,000 related to state income taxes was recorded in the financial statements
for 1998 and 1999.
LIQUIDITY AND CAPITAL RESOURCES
Management assesses the Company's liquidity by its ability to generate cash to
fund its operations. Significant factors in the management of liquidity are:
funds generated by operations; levels of accounts receivable, inventories,
accounts payable and capital expenditures; adequate lines of credit; and
financial flexibility to attract long-term capital on satisfactory terms.
During 1998 and the first six months of 1999, the Company has not generated
sufficient cash from operations to fund its working capital and equipment
purchase requirements. Net cash used in operating activities was $1,338,000 for
the first six months of 1999 versus net cash used in operating activities of
$2,003,000 for the comparable period in 1998. The decrease in the cash used in
operating activities was primarily due to an increase in the interest payable
for the first six months of 1999 versus a reduction of interest payable for the
same period in the prior year.
Net cash used in investing activities was $370,000 in the first six months of
1999, versus net cash used by investing activities of $1,299,000 in the first
six months of 1998. The higher investing activities in the prior year was due to
major purchases of glove production equipment that occurred in the first part of
fiscal 1998.
Net cash provided by financing activities was $1,781,000 in the first six months
of 1999 versus $3,278,000 in the first six months of 1998. The debt financing in
both years was obtained from Trilon Dominion Partners, LLC.
On January 5, 1996, the Company and Trilon Dominion entered into an Agreement
for a credit line of $1,000,000 secured by the Company's assets. Under the terms
of the Agreement, the principal was due on June 30, 1996 and the interest was
payable monthly at a rate of prime plus 3.75%. The Agreement was amended on June
30, 1996, September 30, 1996, April 15, 1997, and September 19, 1997 to a total
credit line of $4 million and a termination date of June 30, 1998. See Note 3 to
the financial statements for details of the Agreement and Amendments.
11
<PAGE> 12
On January 7, 1998, February 17, 1998, and March 10, 1998 the Company and Trilon
Dominion completed Demand Notes, each for $250,000 at an interest rate of
12.25%, to fund the Company's ongoing operations until a new credit facility
could be completed.
On March 31, 1998 the Company and Trilon Dominion completed an Amended and
Restated Credit Agreement and Revolving Line of Credit (the "Amended Agreement")
which included the principal of $4,000,000 from the previous Agreement and
Amendments, the principal of $750,000 from the six Demand Notes, the accrued
interest and management fees of $543,297 on the Agreement and Notes, and a new
credit line commitment of $2,200,000. Under the terms of the Amended Agreement,
the principal of $7,493,297 is due on December 31, 1998, and the interest is
payable quarterly at an annual rate of 11.5%. In connection with the Amended
Agreement, the Company paid Trilon Dominion $100,000 for debt issuance costs and
issued Trilon Dominion a five-year warrant that entitles Trilon Dominion to
purchase 650,000 shares of the Company's authorized but unissued common stock at
an exercise price of $0.41 per share, subject to adjustment to protect against
dilution. The warrant is exercisable immediately and expires on March 31, 2003.
The Company recorded the estimated fair value of the warrant to purchase 650,000
shares as a debt issuance cost in the second quarter of fiscal year 1998 at
$0.07 per underlying common share. Also, under the terms of the Amended
Agreement, the Company issued Trilon Dominion a second five-year warrant which
became exercisable when the Company did not pay the principal and interest due
on December 31, 1998 and expires on March 31, 2003. The second warrant entitles
Trilon Dominion to purchase 250,000 shares of the Company's authorized but
unissued common stock at an exercise price equal to the market price on December
31, 1998. On December 31, 1998, the Company recorded the estimated fair value of
the warrants at $0.07 per underlying common share with a corresponding charge to
earnings of $17,500.
PART II - OTHER INFORMATION
ITEM 1. LEGAL PROCEEDINGS:
For information regarding legal proceedings, refer to the information
contained in the Company's annual report on Form 10-KSB for the fiscal
year ended November 30, 1998 under the heading, "Legal Proceedings" and
Note 6 to the financial statements therein.
ITEM 2. CHANGES IN SECURITIES:
None
ITEM 3. DEFAULTS UPON SENIOR SECURITIES:
None
ITEM 4. SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS:
Registrant has solicited proxies pursuant to regulation 14A of the
Securities Exchange Act (Proxy Statement dated April 6, 1999) for its
Annual Meeting of Shareholders on May 26, 1999. There was no
solicitation in opposition to management's nominees for the directors
listed in the Proxy Statement. All such nominees were elected by the
affirmative vote of 12,673,781 shares. The number of the shares
represented at the meeting was 12,708,983. The number of shares not
voted were 234,402.
ITEM 5. OTHER INFORMATION:
None
12
<PAGE> 13
ITEM 6. EXHIBITS AND REPORTS ON FORM 8-K
(a) EXHIBITS:
10.139 Demand Note dated April 23, 1999 between the Registrant and
Trilon Dominion Partners, L.L.C.
10.140 Demand Note dated May 6, 1999 between the Registrant and Trilon
Dominion Partners, L.L.C.
10.141 Demand Note dated June 7, 1999 between the Registrant and
Trilon Dominion Partners, L.L.C.
10.142 Demand Note dated July 5, 1999 between the Registrant and
Trilon Dominion Partners, L.L.C.
10.143 Form of stock option granted on April 15, 1999 to Mr. Paul
Fennell.
10.144 Form of stock option granted on April 15, 1999 to Mr. Dan
Jennings.
10.145 Form of stock option granted on April 15, 1999 to Mr. Shawn
Roberts.
10.146 Form of stock option granted on May 12, 1999 to Mr. Lee Jarad.
10.147 Form of stock option granted on May 12, 1999 to Mr. Ben Zarza.
10.148 Form of stock option granted on April 15, 1999 to Ms. Grace
Reasoner.
27 Financial Data Schedule
(b) REPORTS ON FORM 8-K:
None
SIGNATURES
In accordance with requirements of the Securities Exchange Act, the registrant
has caused this report to be signed on its behalf by the undersigned, thereunto
duly authorized.
WILSHIRE TECHNOLOGIES, INC.
Dated: July 14, 1999 By: /s/ Kathleen E. Terry
--------------------------
Kathleen E. Terry
Chief Financial Officer
(Principal Financial Officer and
Principal Accounting Officer)
13
<PAGE> 1
EXHIBIT 10.139
DEMAND NOTE
$250,000.00 New York, New York
April 23, 1999
FOR VALUE RECEIVED, the undersigned, Wilshire Technologies, Inc. a
California corporation (hereinafter referred to as "Borrower"), hereby
unconditionally PROMISES TO PAY to the order to TRILON DOMINION PARTNERS, LLC, a
Delaware limited liability company ("Lender"), at 245 Park Avenue, 28th Floor,
New York, NY 10167, or at such other place as the holder of this Demand Note may
designate from time to time in writing, in lawful money of the United States of
America and in immediately available funds, the principal amount of Two Hundred
Fifty Thousand and 00/100, DOLLARS ($250,000.00), together with interest on the
unpaid principal amount of this Demand Note outstanding from time to time from
the date hereof, at a rate per annum equal to the Prime rate of interest of 8.5%
plus 3.0%, or the highest rate permitted by law, whichever shall be less.
The principal amount of the indebtedness evidenced hereby shall be
payable on demand. Interest thereon shall be paid when principal is paid from
the date hereof until such principal amount is paid in full at such interest
rate as specified above. Following failure to pay on demand, Borrower agrees to
pay interest on any overdue payment of principal at a rate per annum equal to
the stated interest rate plus 5%, or the highest rate permitted by law,
whichever shall be less. All interest calculations shall be computed on the
basis of a 360 day year.
Demand, presentment, protest and notice of nonpayment and protest are
hereby waived by Borrower.
Borrower shall have no right to make any off-set against or deduct from
any payment due under this Demand Note.
Principal and interest may be prepaid at any time without penalty.
This Demand Note may not be changed orally, but only by an agreement in
writing and signed by the party against whom enforcement of such change is
sought.
All covenants of Borrower in this Demand Note and all rights of the
holder under this Demand Note shall bind Borrower and its successors and
assigns, and all such covenants and rights shall inure to the benefit of the
holder of this Demand Note and its successors and assigns.
This Demand Note has been delivered and accepted at New York, New York
and shall be interpreted, governed by, and construed in accordance with, the
laws of the State of New York.
Wilshire Technologies, Inc.
By: /s/ Kathleen E. Terry
-----------------------------
Name: Kathleen E. Terry
Title: Chief Financial Officer
<PAGE> 1
EXHIBIT 10.140
DEMAND NOTE
$250,000.00 New York, New York
May 6, 1999
FOR VALUE RECEIVED, the undersigned, Wilshire Technologies, Inc. a
California corporation (hereinafter referred to as "Borrower"), hereby
unconditionally PROMISES TO PAY to the order to TRILON DOMINION PARTNERS, LLC, a
Delaware limited liability company ("Lender"), at 245 Park Avenue, 28th Floor,
New York, NY 10167, or at such other place as the holder of this Demand Note may
designate from time to time in writing, in lawful money of the United States of
America and in immediately available funds, the principal amount of Two Hundred
Fifty Thousand and 00/100, DOLLARS ($250,000.00), together with interest on the
unpaid principal amount of this Demand Note outstanding from time to time from
the date hereof, at a rate per annum equal to the Prime rate of interest of 8.5%
plus 3.0%, or the highest rate permitted by law, whichever shall be less.
The principal amount of the indebtedness evidenced hereby shall be
payable on demand. Interest thereon shall be paid when principal is paid from
the date hereof until such principal amount is paid in full at such interest
rate as specified above. Following failure to pay on demand, Borrower agrees to
pay interest on any overdue payment of principal at a rate per annum equal to
the stated interest rate plus 5%, or the highest rate permitted by law,
whichever shall be less. All interest calculations shall be computed on the
basis of a 360 day year.
Demand, presentment, protest and notice of nonpayment and protest are
hereby waived by Borrower.
Borrower shall have no right to make any off-set against or deduct from
any payment due under this Demand Note.
Principal and interest may be prepaid at any time without penalty.
This Demand Note may not be changed orally, but only by an agreement in
writing and signed by the party against whom enforcement of such change is
sought.
All covenants of Borrower in this Demand Note and all rights of the
holder under this Demand Note shall bind Borrower and its successors and
assigns, and all such covenants and rights shall inure to the benefit of the
holder of this Demand Note and its successors and assigns.
This Demand Note has been delivered and accepted at New York, New York
and shall be interpreted, governed by, and construed in accordance with, the
laws of the State of New York.
Wilshire Technologies, Inc.
By: /s/ Kathleen E. Terry
-----------------------------
Name: Kathleen E. Terry
Title: Chief Financial Officer
<PAGE> 1
EXHIBIT 10.141
DEMAND NOTE
$250,000.00 New York, New York
June 7, 1999
FOR VALUE RECEIVED, the undersigned, Wilshire Technologies, Inc. a
California corporation (hereinafter referred to as "Borrower"), hereby
unconditionally PROMISES TO PAY to the order to TRILON DOMINION PARTNERS, LLC, a
Delaware limited liability company ("Lender"), at 245 Park Avenue, 28th Floor,
New York, NY 10167, or at such other place as the holder of this Demand Note may
designate from time to time in writing, in lawful money of the United States of
America and in immediately available funds, the principal amount of Two Hundred
Fifty Thousand and 00/100, DOLLARS ($250,000.00), together with interest on the
unpaid principal amount of this Demand Note outstanding from time to time from
the date hereof, at a rate per annum equal to the Prime rate of interest of 8.5%
plus 3.0%, or the highest rate permitted by law, whichever shall be less.
The principal amount of the indebtedness evidenced hereby shall be
payable on demand. Interest thereon shall be paid when principal is paid from
the date hereof until such principal amount is paid in full at such interest
rate as specified above. Following failure to pay on demand, Borrower agrees to
pay interest on any overdue payment of principal at a rate per annum equal to
the stated interest rate plus 5%, or the highest rate permitted by law,
whichever shall be less. All interest calculations shall be computed on the
basis of a 360 day year.
Demand, presentment, protest and notice of nonpayment and protest are
hereby waived by Borrower.
Borrower shall have no right to make any off-set against or deduct from
any payment due under this Demand Note.
Principal and interest may be prepaid at any time without penalty.
This Demand Note may not be changed orally, but only by an agreement in
writing and signed by the party against whom enforcement of such change is
sought.
All covenants of Borrower in this Demand Note and all rights of the
holder under this Demand Note shall bind Borrower and its successors and
assigns, and all such covenants and rights shall inure to the benefit of the
holder of this Demand Note and its successors and assigns.
This Demand Note has been delivered and accepted at New York, New York
and shall be interpreted, governed by, and construed in accordance with, the
laws of the State of New York.
Wilshire Technologies, Inc.
By: /s/ Kathleen E. Terry
-----------------------------
Name: Kathleen E. Terry
Title: Chief Financial Officer
<PAGE> 1
EXHIBIT 10.142
DEMAND NOTE
$250,000.00 New York, New York
July 5, 1999
FOR VALUE RECEIVED, the undersigned, Wilshire Technologies, Inc. a
California corporation (hereinafter referred to as "Borrower"), hereby
unconditionally PROMISES TO PAY to the order to TRILON DOMINION PARTNERS, LLC, a
Delaware limited liability company ("Lender"), at 245 Park Avenue, 28th Floor,
New York, NY 10167, or at such other place as the holder of this Demand Note may
designate from time to time in writing, in lawful money of the United States of
America and in immediately available funds, the principal amount of Two Hundred
Fifty Thousand and 00/100, DOLLARS ($250,000.00), together with interest on the
unpaid principal amount of this Demand Note outstanding from time to time from
the date hereof, at a rate per annum equal to the Prime rate of interest plus
3.0%, or the highest rate permitted by law, whichever shall be less.
The principal amount of the indebtedness evidenced hereby shall be
payable on demand. Interest thereon shall be paid when principal is paid from
the date hereof until such principal amount is paid in full at such interest
rate as specified above. Following failure to pay on demand, Borrower agrees to
pay interest on any overdue payment of principal at a rate per annum equal to
the stated interest rate plus 5%, or the highest rate permitted by law,
whichever shall be less. All interest calculations shall be computed on the
basis of a 360 day year.
Demand, presentment, protest and notice of nonpayment and protest are
hereby waived by Borrower.
Borrower shall have no right to make any off-set against or deduct from
any payment due under this Demand Note.
Principal and interest may be prepaid at any time without penalty.
This Demand Note may not be changed orally, but only by an agreement in
writing and signed by the party against whom enforcement of such change is
sought.
All covenants of Borrower in this Demand Note and all rights of the
holder under this Demand Note shall bind Borrower and its successors and
assigns, and all such covenants and rights shall inure to the benefit of the
holder of this Demand Note and its successors and assigns.
This Demand Note has been delivered and accepted at New York, New York
and shall be interpreted, governed by, and construed in accordance with, the
laws of the State of New York.
Wilshire Technologies, Inc.
By: /s/ Kathleen E. Terry
-----------------------------
Name: Kathleen E. Terry
Title:Chief Financial Officer
<PAGE> 1
EXHIBIT 10.143
WILSHIRE TECHNOLOGIES, INC.
NON-QUALIFIED STOCK OPTION
1995 STOCK OPTION PLAN
THIS IS TO CERTIFY that on APRIL 15, 1999, WILSHIRE TECHNOLOGIES, INC., a
California corporation (the "Company") has granted to PAUL FENNELL (the
"Optionee") an option to purchase 50,000 shares of common stock of the Company,
no par value, at a price of $0.35 per share, upon the terms and conditions
hereinafter stated, to all of which the Optionee, by the acceptance hereof,
assents.
1. Option Period and Conditions on Exercise.
The option shall not be exercisable with respect to any of the shares
subject to the option after APRIL 15, 2009 and the option shall not be
exercisable with respect to fractional shares.
This option vests as follows:
As to 16,666 shares on APRIL 15, 1999; and
As to an additional 16,667 shares on APRIL 15, 2000;
As to an additional 16,667 shares on APRIL 15, 2001.
1
<PAGE> 2
2. Effect of Termination of Employment/Effect of Death.
a. If the Optionee is an officer, employee or director of the Company and
ceases to be such for any reason other than death or termination for
cause, Optionee may exercise this option in accordance with its terms
only for a period of ninety days after such cessation (but not beyond
the Option Period). Any exercise of this option after such cessation may
be only to the extent of the full number of shares the Optionee was
entitled to purchase under this option on the Date of such cessation,
plus a portion of the additional number of shares, if any, he would have
become entitled to purchase on the next anniversary Date of the Date of
grant of the option following such cessation, such portion to be
determined by multiplying such additional number of shares by a
fraction, the numerator of which is the number of days from the
anniversary Date of the Date of grant preceding such cessation to the
Date of such cessation and the denominator of which is 365. Such portion
shall be rounded, if necessary, to the nearest whole share.
b. If the termination of the Optionee's position as an officer or employee
of the Company is for cause (as determined in the sole judgment of the
Board of Directors), this option shall thereupon be cancelled and the
Optionee shall have no right to exercise any part of this option after
such termination.
c. If the Optionee dies, this option continues in effect and may be
exercised in accordance with its terms for twelve months from the date
of the Optionee's death
2
<PAGE> 3
(but not beyond the Option Period) by the executor or administrator of
the estate, or in the event there is none, then by the person or persons
to whom the optionee's rights under this option shall pass by will or
the laws of descent and distribution. Any exercise of this option after
such death may be only to the extent of the full number of shares the
optionee was entitled to purchase under this option on the date of
death, plus a portion of the additional number of shares, if any, he
would have become entitled to purchase on the next anniversary date of
the date of grant of the option following such death, such portion to be
determined by multiplying such additional number of shares by a
fraction, the numerator of which shall be the number of days from the
anniversary Date of the Date of grant preceding such death to the Date
of death and the denominator of which shall be 365. Such portion shall
be rounded, if necessary, to the nearest whole share.
3. Manner of Exercise.
This option shall be exercised by giving written notice to the Company
addressed in the manner specified in paragraph 7, specifying the number of
shares to be purchased and accompanied by payment in full in cash, or in
whole or in part in Common Stock, as provided in paragraph 9, for the shares
purchased.
3
<PAGE> 4
4. Nontransferability of Option.
This option shall not be transferable except to the executor or
administrator of the Optionee's estate or to the Optionee's heirs or
legatees, and shall be exercisable during the Optionee's lifetime only
by the Optionee. This option may, however, be surrendered to the Company
for cancellation for such consideration and upon such terms as may be
mutually agreed upon by the Company and the Optionee.
5. Adjustment of Shares and Price Per Share.
The number of shares subject to this option shall be adjusted as
follows:
a. In the event the Company's outstanding common stock is changed
by any stock dividend, stock split, or combination of shares,
the number of shares subject to this option shall be
proportionately adjusted, without change in the aggregate
purchase price.
b. Except as provided in subsection (d) hereof, in the event of any
merger, consolidation, or reorganization of the Company with any
other corporation or corporations, there shall be substituted on
an equitable basis, for each share of common stock then subject
to this option, an option for the number and kind of shares of
stock or other securities to which the holders of common stock
of the Company will be entitled pursuant to the transaction.
c. In the event of any other relevant change in the capitalization
of the Company, this option and the purchase price per share
shall be equitably adjusted.
d. In the event of a merger described in Section 368 (a)(2)(E) of
the Internal Revenue Code of 1986 in
4
<PAGE> 5
which the Company is the surviving corporation, this option
shall terminate and thereupon become null and void but only if
the controlling corporation shall agree to exchange its options
for this option; but the Optionee shall have the right,
immediately prior to such merger, to exercise this option,
without regard to any otherwise applicable restriction as to
time of exercise, other than expiration of the Option Period.
e. Upon the dissolution of the Company, this option shall terminate
and thereafter become null and void; but the Optionee shall have
the right, immediately prior to such dissolution, to exercise
this option without regard to any otherwise applicable
restriction as to time of exercise, other than expiration of the
Option Period.
6. Compliance with Applicable Law.
The exercise of this option is subject to the obtaining of any consent
or approval of any governmental or other regulatory body which the Board
of Directors, in its discretion, deems necessary or desirable.
7. Other Provisions.
a. The holder of this option shall not be entitled to any rights of
a shareholder of the Company with respect to any shares subject
to this option until such shares have been paid for in full and
issued to him.
b. Nothing in this Certificate shall be construed as limiting any
rights which the Company or any parent or
5
<PAGE> 6
subsidiary corporation of the Company may have to terminate at
any time the employment of the Optionee.
c. Notice to the Company hereunder shall be addressed to the
attention of its Secretary at its corporate office at 5861
Edison Place, Carlsbad, California 92008.
8. Incorporation of Plan by Reference.
EXCEPT AS MODIFIED OR AMPLIFIED BY THE SPECIFIC TERMS OF THIS AGREEMENT,
ALL OF THE TERMS AND PROVISIONS OF THE WILSHIRE TECHNOLOGIES, INC. 1995
STOCK OPTION PLAN (THE "PLAN"), A COPY OF WHICH IS ATTACHED HERETO AS
EXHIBIT A, ARE INCORPORATED HEREIN AND MADE A PART HEREOF AS IF SET
FORTH AT LENGTH HEREIN.
9. Optional Form of Payment for Shares.
Payment for any number of shares of stock of the Company purchased
pursuant to the exercise of this option may, at the election of the
Optionee, be made by delivering to the Company a number of shares of the
Common Stock of the Company, which the Optionee has owned for at least
six months, with a Fair Market Value (as defined in the Plan), on the
date this option is exercised, equal to the option exercise price for
such shares.
WILSHIRE TECHNOLOGIES, INC.
By /s/ Kevin T. Mulvihill
-----------------------------------
President & Chief Executive Officer
6
<PAGE> 7
I hereby accept the foregoing stock option on the terms and conditions
hereinabove stated.
OPTIONEE,
---------------------
(Please print or type)
Date:______________ Signature:_________________
7
<PAGE> 8
EXERCISE OF OPTION
The undersigned hereby irrevocably elects to exercise the right
to purchase _______________ shares of Common Stock of Wilshire Technologies,
Inc. (the "Shares"), such right being represented by the Stock Option granted to
me on ______________ and herewith tenders payment for the Shares to the order of
Wilshire Technologies, Inc., in the amount of $________________ (equal to [the
number of shares] multiplied by $_________ [the exercise price stated in the
Stock Option]).
The undersigned requests that a certificate for the Shares be
registered in the of ____________, and delivered to, the undersigned at the
following address:_________________________________________________________
___________________________________________________________________________
___________________________________________________________________________
___________________________________________________________________________
------------------------------------
(Please print or type)
Date: Signature
--------------- ---------------------------
Social Security Number______-___-_______
8
<PAGE> 1
EXHIBIT 10.144
WILSHIRE TECHNOLOGIES, INC.
NON-QUALIFIED STOCK OPTION
1995 STOCK OPTION PLAN
THIS IS TO CERTIFY that on APRIL 15, 1999, WILSHIRE TECHNOLOGIES, INC., a
California corporation (the "Company") has granted to DAN JENNINGS (the
"Optionee") an option to purchase 30,000 shares of common stock of the Company,
no par value, at a price of $0.35 per share, upon the terms and conditions
hereinafter stated, to all of which the Optionee, by the acceptance hereof,
assents.
1. Option Period and Conditions on Exercise.
The option shall not be exercisable with respect to any of the shares
subject to the option after APRIL 15, 2009 and the option shall not be
exercisable with respect to fractional shares.
This option vests as follows:
As to 10,000 shares on APRIL 15, 1999; and
As to an additional 10,000 shares on APRIL 15, 2000;
As to an additional 10,000 shares on APRIL 15, 2001.
<PAGE> 2
2. Effect of Termination of Employment/Effect of Death.
a. If the Optionee is an officer, employee or director of the
Company and ceases to be such for any reason other than death or
termination for cause, Optionee may exercise this option in
accordance with its terms only for a period of ninety days after
such cessation (but not beyond the Option Period). Any exercise
of this option after such cessation may be only to the extent of
the full number of shares the Optionee was entitled to purchase
under this option on the Date of such cessation, plus a portion
of the additional number of shares, if any, he would have become
entitled to purchase on the next anniversary Date of the Date of
grant of the option following such cessation, such portion to be
determined by multiplying such additional number of shares by a
fraction, the numerator of which is the number of days from the
anniversary Date of the Date of grant preceding such cessation
to the Date of such cessation and the denominator of which is
365. Such portion shall be rounded, if necessary, to the nearest
whole share.
b. If the termination of the Optionee's position as an officer or
employee of the Company is for cause (as determined in the sole
judgment of the Board of Directors), this option shall thereupon
be cancelled and the Optionee shall have no right to exercise
any part of this option after such termination.
c. If the Optionee dies, this option continues in effect and may be
exercised in accordance with its terms for twelve months from
the date of the Optionee's death
2
<PAGE> 3
(but not beyond the Option Period) by the executor or
administrator of the estate, or in the event there is none, then
by the person or persons to whom the optionee's rights under
this option shall pass by will or the laws of descent and
distribution. Any exercise of this option after such death may
be only to the extent of the full number of shares the optionee
was entitled to purchase under this option on the date of death,
plus a portion of the additional number of shares, if any, he
would have become entitled to purchase on the next anniversary
date of the date of grant of the option following such death,
such portion to be determined by multiplying such additional
number of shares by a fraction, the numerator of which shall be
the number of days from the anniversary Date of the Date of
grant preceding such death to the Date of death and the
denominator of which shall be 365. Such portion shall be
rounded, if necessary, to the nearest whole share.
3. Manner of Exercise.
This option shall be exercised by giving written notice to the Company
addressed in the manner specified in paragraph 7, specifying the number
of shares to be purchased and accompanied by payment in full in cash, or
in whole or in part in Common Stock, as provided in paragraph 9, for the
shares purchased.
3
<PAGE> 4
4. Nontransferability of Option.
This option shall not be transferable except to the executor or
administrator of the Optionee's estate or to the Optionee's heirs or
legatees, and shall be exercisable during the Optionee's lifetime only
by the Optionee. This option may, however, be surrendered to the Company
for cancellation for such consideration and upon such terms as may be
mutually agreed upon by the Company and the Optionee.
5. Adjustment of Shares and Price Per Share.
The number of shares subject to this option shall be adjusted as
follows:
a. In the event the Company's outstanding common stock is changed
by any stock dividend, stock split, or combination of shares,
the number of shares subject to this option shall be
proportionately adjusted, without change in the aggregate
purchase price.
b. Except as provided in subsection (d) hereof, in the event of any
merger, consolidation, or reorganization of the Company with any
other corporation or corporations, there shall be substituted on
an equitable basis, for each share of common stock then subject
to this option, an option for the number and kind of shares of
stock or other securities to which the holders of common stock
of the Company will be entitled pursuant to the transaction.
c. In the event of any other relevant change in the capitalization
of the Company, this option and the purchase price per share
shall be equitably adjusted.
d. In the event of a merger described in Section 368 (a)(2)(E) of
the Internal Revenue Code of 1986 in
4
<PAGE> 5
which the Company is the surviving corporation, this option
shall terminate and thereupon become null and void but only if
the controlling corporation shall agree to exchange its options
for this option; but the Optionee shall have the right,
immediately prior to such merger, to exercise this option,
without regard to any otherwise applicable restriction as to
time of exercise, other than expiration of the Option Period.
e. Upon the dissolution of the Company, this option shall terminate
and thereafter become null and void; but the Optionee shall have
the right, immediately prior to such dissolution, to exercise
this option without regard to any otherwise applicable
restriction as to time of exercise, other than expiration of the
Option Period.
6. Compliance with Applicable Law.
The exercise of this option is subject to the obtaining of any consent
or approval of any governmental or other regulatory body which the Board
of Directors, in its discretion, deems necessary or desirable.
7. Other Provisions.
a. The holder of this option shall not be entitled to any rights of
a shareholder of the Company with respect to any shares subject
to this option until such shares have been paid for in full and
issued to him.
b. Nothing in this Certificate shall be construed as limiting any
rights which the Company or any parent or
5
<PAGE> 6
subsidiary corporation of the Company may have to terminate at
any time the employment of the Optionee.
c. Notice to the Company hereunder shall be addressed to the
attention of its Secretary at its corporate office at 5861 Edison
Place, Carlsbad, California 92008.
8. Incorporation of Plan by Reference.
EXCEPT AS MODIFIED OR AMPLIFIED BY THE SPECIFIC TERMS OF THIS AGREEMENT,
ALL OF THE TERMS AND PROVISIONS OF THE WILSHIRE TECHNOLOGIES, INC. 1995
STOCK OPTION PLAN (THE "PLAN"), A COPY OF WHICH IS ATTACHED HERETO AS
EXHIBIT A, ARE INCORPORATED HEREIN AND MADE A PART HEREOF AS IF SET
FORTH AT LENGTH HEREIN.
9. Optional Form of Payment for Shares.
Payment for any number of shares of stock of the Company purchased
pursuant to the exercise of this option may, at the election of the
Optionee, be made by delivering to the Company a number of shares of the
Common Stock of the Company, which the Optionee has owned for at least
six months, with a Fair Market Value (as defined in the Plan), on the
date this option is exercised, equal to the option exercise price for
such shares.
WILSHIRE TECHNOLOGIES, INC.
By /s/ Kevin T. Mulvihill
-------------------------------------
President & Chief Executive Officer
6
<PAGE> 7
I hereby accept the foregoing stock option on the terms and conditions
hereinabove stated.
OPTIONEE,
---------------------
(Please print or type)
Date:______________ Signature:____________________________
7
<PAGE> 8
EXERCISE OF OPTION
The undersigned hereby irrevocably elects to exercise the right
to purchase _______________ shares of Common Stock of Wilshire Technologies,
Inc. (the "Shares"), such right being represented by the Stock Option granted to
me on ______________ and herewith tenders payment for the Shares to the order of
Wilshire Technologies, Inc., in the amount of $________________ (equal to [the
number of shares] multiplied by $_________ [the exercise price stated in the
Stock Option]).
The undersigned requests that a certificate for the Shares be
registered in the name of _________________, and delivered to, the undersigned
at the following address:_____________________________________________________
______________________________________________________________________________
______________________________________________________________________________
------------------------------------
(Please print or type)
Date:___________ Signature_______________________________
Social Security Number______-___-_______
8
<PAGE> 1
EXHIBIT 10.145
WILSHIRE TECHNOLOGIES, INC.
NON-QUALIFIED STOCK OPTION
1995 STOCK OPTION PLAN
THIS IS TO CERTIFY that on APRIL 15, 1999, WILSHIRE TECHNOLOGIES, INC., a
California corporation (the "Company") has granted to SHAWN ROBERTS (the
"Optionee") an option to purchase 30,000 shares of common stock of the Company,
no par value, at a price of $0.35 per share, upon the terms and conditions
hereinafter stated, to all of which the Optionee, by the acceptance hereof,
assents.
1. Option Period and Conditions on Exercise.
The option shall not be exercisable with respect to any of the shares
subject to the option after APRIL 15, 2009 and the option shall not be
exercisable with respect to fractional shares.
This option vests as follows:
As to 10,000 shares on APRIL 15, 1999; and
As to an additional 10,000 shares on APRIL 15, 2000;
As to an additional 10,000 shares on APRIL 15, 2001.
1
<PAGE> 2
2. Effect of Termination of Employment/Effect of Death.
a. If the Optionee is an officer, employee or director of the
Company and ceases to be such for any reason other than death or
termination for cause, Optionee may exercise this option in
accordance with its terms only for a period of ninety days after
such cessation (but not beyond the Option Period). Any exercise
of this option after such cessation may be only to the extent of
the full number of shares the Optionee was entitled to purchase
under this option on the Date of such cessation, plus a portion
of the additional number of shares, if any, he would have become
entitled to purchase on the next anniversary Date of the Date of
grant of the option following such cessation, such portion to be
determined by multiplying such additional number of shares by a
fraction, the numerator of which is the number of days from the
anniversary Date of the Date of grant preceding such cessation
to the Date of such cessation and the denominator of which is
365. Such portion shall be rounded, if necessary, to the nearest
whole share.
b. If the termination of the Optionee's position as an officer or
employee of the Company is for cause (as determined in the sole
judgment of the Board of Directors), this option shall thereupon
be cancelled and the Optionee shall have no right to exercise
any part of this option after such termination.
c. If the Optionee dies, this option continues in effect and may be
exercised in accordance with its terms for twelve months from
the date of the Optionee's death
2
<PAGE> 3
(but not beyond the Option Period) by the executor or
administrator of the estate, or in the event there is none, then
by the person or persons to whom the optionee's rights under
this option shall pass by will or the laws of descent and
distribution. Any exercise of this option after such death may
be only to the extent of the full number of shares the optionee
was entitled to purchase under this option on the date of death,
plus a portion of the additional number of shares, if any, he
would have become entitled to purchase on the next anniversary
date of the date of grant of the option following such death,
such portion to be determined by multiplying such additional
number of shares by a fraction, the numerator of which shall be
the number of days from the anniversary Date of the Date of
grant preceding such death to the Date of death and the
denominator of which shall be 365. Such portion shall be
rounded, if necessary, to the nearest whole share.
3. Manner of Exercise.
This option shall be exercised by giving written notice to the Company
addressed in the manner specified in paragraph 7, specifying the number
of shares to be purchased and accompanied by payment in full in cash, or
in whole or in part in Common Stock, as provided in paragraph 9, for the
shares purchased.
3
<PAGE> 4
4. Nontransferability of Option.
This option shall not be transferable except to the executor or
administrator of the Optionee's estate or to the Optionee's heirs or
legatees, and shall be exercisable during the Optionee's lifetime only
by the Optionee. This option may, however, be surrendered to the Company
for cancellation for such consideration and upon such terms as may be
mutually agreed upon by the Company and the Optionee.
5. Adjustment of Shares and Price Per Share.
The number of shares subject to this option shall be adjusted as
follows:
a. In the event the Company's outstanding common stock is changed
by any stock dividend, stock split, or combination of shares,
the number of shares subject to this option shall be
proportionately adjusted, without change in the aggregate
purchase price.
b. Except as provided in subsection (d) hereof, in the event of any
merger, consolidation, or reorganization of the Company with any
other corporation or corporations, there shall be substituted on
an equitable basis, for each share of common stock then subject
to this option, an option for the number and kind of shares of
stock or other securities to which the holders of common stock of
the Company will be entitled pursuant to the transaction.
c. In the event of any other relevant change in the capitalization
of the Company, this option and the purchase price per share
shall be equitably adjusted.
d. In the event of a merger described in Section 368 (a)(2)(E) of
the Internal Revenue Code of 1986 in
4
<PAGE> 5
which the Company is the surviving corporation, this option
shall terminate and thereupon become null and void but only if
the controlling corporation shall agree to exchange its options
for this option; but the Optionee shall have the right,
immediately prior to such merger, to exercise this option,
without regard to any otherwise applicable restriction as to
time of exercise, other than expiration of the Option Period.
e. Upon the dissolution of the Company, this option shall terminate
and thereafter become null and void; but the Optionee shall have
the right, immediately prior to such dissolution, to exercise
this option without regard to any otherwise applicable
restriction as to time of exercise, other than expiration of the
Option Period.
6. Compliance with Applicable Law.
The exercise of this option is subject to the obtaining of any consent
or approval of any governmental or other regulatory body which the Board
of Directors, in its discretion, deems necessary or desirable.
7. Other Provisions.
a. The holder of this option shall not be entitled to any rights of
a shareholder of the Company with respect to any shares subject
to this option until such shares have been paid for in full and
issued to him.
b. Nothing in this Certificate shall be construed as limiting any
rights which the Company or any parent or
5
<PAGE> 6
subsidiary corporation of the Company may have to terminate at
any time the employment of the Optionee.
c. Notice to the Company hereunder shall be addressed to the
attention of its Secretary at its corporate office at 5861 Edison
Place, Carlsbad, California 92008.
8. Incorporation of Plan by Reference.
EXCEPT AS MODIFIED OR AMPLIFIED BY THE SPECIFIC TERMS OF THIS AGREEMENT,
ALL OF THE TERMS AND PROVISIONS OF THE WILSHIRE TECHNOLOGIES, INC. 1995
STOCK OPTION PLAN (THE "PLAN"), A COPY OF WHICH IS ATTACHED HERETO AS
EXHIBIT A, ARE INCORPORATED HEREIN AND MADE A PART HEREOF AS IF SET
FORTH AT LENGTH HEREIN.
9. Optional Form of Payment for Shares.
Payment for any number of shares of stock of the Company purchased
pursuant to the exercise of this option may, at the election of the
Optionee, be made by delivering to the Company a number of shares of the
Common Stock of the Company, which the Optionee has owned for at least
six months, with a Fair Market Value (as defined in the Plan), on the
date this option is exercised, equal to the option exercise price for
such shares.
WILSHIRE TECHNOLOGIES, INC.
By /S/ KEVIN MULVIHILL
--------------------------------------
President & Chief Executive Officer
6
<PAGE> 7
I hereby accept the foregoing stock option on the terms and conditions
hereinabove stated.
OPTIONEE,
---------------------
(Please print or type)
Date:______________ Signature:_________________
7
<PAGE> 8
EXERCISE OF OPTION
The undersigned hereby irrevocably elects to exercise the right
to purchase _______________ shares of Common Stock of Wilshire Technologies,
Inc. (the "Shares"), such right being represented by the Stock Option granted to
me on ______________ and herewith tenders payment for the Shares to the order of
Wilshire Technologies, Inc., in the amount of $________________ (equal to [the
number of shares] multiplied by $_________ [the exercise price stated in the
Stock Option]).
The undersigned requests that a certificate for the Shares be
registered in the name of_____________, and delivered to, the undersigned at the
following address:______________________________________________________________
________________________________________________________________________________
________________________________________________________________________________
------------------------------------
(Please print or type)
Date:___________ Signature_______________________________
Social Security Number______-___-_______
8
<PAGE> 1
EXHIBIT 10.146
WILSHIRE TECHNOLOGIES, INC.
NON-QUALIFIED STOCK OPTION
1995 STOCK OPTION PLAN
THIS IS TO CERTIFY that on MAY 12, 1999, WILSHIRE TECHNOLOGIES, INC., a
California corporation (the "Company") has granted to LEE JARED (the "Optionee")
an option to purchase 10,000 shares of common stock of the Company, no par
value, at a price of $0.75 per share, upon the terms and conditions hereinafter
stated, to all of which the Optionee, by the acceptance hereof, assents.
1. Option Period and Conditions on Exercise.
The option shall not be exercisable with respect to any of the shares
subject to the option after MAY 12, 2009 and the option shall not be
exercisable with respect to fractional shares.
This option vests as follows:
As to 3,334 shares on MAY 12, 1999; and
As to an additional 3,333 shares on MAY 12, 1999;
As to an additional 3,333 shares on MAY 12, 2001.
1
<PAGE> 2
2. Effect of Termination of Employment/Effect of Death.
a. If the Optionee is an officer, employee or director of the
Company and ceases to be such for any reason other than death or
termination for cause, Optionee may exercise this option in
accordance with its terms only for a period of ninety days after
such cessation (but not beyond the Option Period). Any exercise
of this option after such cessation may be only to the extent of
the full number of shares the Optionee was entitled to purchase
under this option on the Date of such cessation, plus a portion
of the additional number of shares, if any, he would have become
entitled to purchase on the next anniversary Date of the Date of
grant of the option following such cessation, such portion to be
determined by multiplying such additional number of shares by a
fraction, the numerator of which is the number of days from the
anniversary Date of the Date of grant preceding such cessation
to the Date of such cessation and the denominator of which is
365. Such portion shall be rounded, if necessary, to the nearest
whole share.
b. If the termination of the Optionee's position as an officer or
employee of the Company is for cause (as determined in the sole
judgment of the Board of Directors), this option shall thereupon
be cancelled and the Optionee shall have no right to exercise
any part of this option after such termination.
c. If the Optionee dies, this option continues in effect and may be
exercised in accordance with its terms for twelve months from
the date of the Optionee's death
2
<PAGE> 3
(but not beyond the Option Period) by the executor or
administrator of the estate, or in the event there is none, then
by the person or persons to whom the optionee's rights under
this option shall pass by will or the laws of descent and
distribution. Any exercise of this option after such death may
be only to the extent of the full number of shares the optionee
was entitled to purchase under this option on the date of death,
plus a portion of the additional number of shares, if any, he
would have become entitled to purchase on the next anniversary
date of the date of grant of the option following such death,
such portion to be determined by multiplying such additional
number of shares by a fraction, the numerator of which shall be
the number of days from the anniversary Date of the Date of
grant preceding such death to the Date of death and the
denominator of which shall be 365. Such portion shall be
rounded, if necessary, to the nearest whole share.
3. Manner of Exercise.
This option shall be exercised by giving written notice to the Company
addressed in the manner specified in paragraph 7, specifying the number
of shares to be purchased and accompanied by payment in full in cash, or
in whole or in part in Common Stock, as provided in paragraph 9, for the
shares purchased.
3
<PAGE> 4
4. Nontransferability of Option.
This option shall not be transferable except to the executor or
administrator of the Optionee's estate or to the Optionee's heirs or
legatees, and shall be exercisable during the Optionee's lifetime only
by the Optionee. This option may, however, be surrendered to the Company
for cancellation for such consideration and upon such terms as may be
mutually agreed upon by the Company and the Optionee.
5. Adjustment of Shares and Price Per Share.
The number of shares subject to this option shall be adjusted as
follows:
a. In the event the Company's outstanding common stock is changed
by any stock dividend, stock split, or combination of shares,
the number of shares subject to this option shall be
proportionately adjusted, without change in the aggregate
purchase price.
b. Except as provided in subsection (d) hereof, in the event of any
merger, consolidation, or reorganization of the Company with any
other corporation or corporations, there shall be substituted on
an equitable basis, for each share of common stock then subject
to this option, an option for the number and kind of shares of
stock or other securities to which the holders of common stock of
the Company will be entitled pursuant to the transaction.
c. In the event of any other relevant change in the capitalization
of the Company, this option and the purchase price per share
shall be equitably adjusted.
d. In the event of a merger described in Section 368(a)(2)(E) of
the Internal Revenue Code of 1986 in
4
<PAGE> 5
which the Company is the surviving corporation, this option shall
terminate and thereupon become null and void but only if the
controlling corporation shall agree to exchange its options for
this option; but the Optionee shall have the right, immediately
prior to such merger, to exercise this option, without regard to
any otherwise applicable restriction as to time of exercise,
other than expiration of the Option Period.
e. Upon the dissolution of the Company, this option shall terminate
and thereafter become null and void; but the Optionee shall have
the right, immediately prior to such dissolution, to exercise
this option without regard to any otherwise applicable
restriction as to time of exercise, other than expiration of the
Option Period.
6. Compliance with Applicable Law.
The exercise of this option is subject to the obtaining of any consent
or approval of any governmental or other regulatory body which the Board
of Directors, in its discretion, deems necessary or desirable.
7. Other Provisions.
a. The holder of this option shall not be entitled to any rights of
a shareholder of the Company with respect to any shares subject
to this option until such shares have been paid for in full and
issued to him.
b. Nothing in this Certificate shall be construed as limiting any
rights which the Company or any parent or
5
<PAGE> 6
subsidiary corporation of the Company may have to terminate at
any time the employment of the Optionee.
c. Notice to the Company hereunder shall be addressed to the
attention of its Secretary at its corporate office at 5861 Edison
Place, Carlsbad, California 92008.
8. Incorporation of Plan by Reference.
EXCEPT AS MODIFIED OR AMPLIFIED BY THE SPECIFIC TERMS OF THIS AGREEMENT,
ALL OF THE TERMS AND PROVISIONS OF THE WILSHIRE TECHNOLOGIES, INC. 1995
STOCK OPTION PLAN (THE "PLAN"), A COPY OF WHICH IS ATTACHED HERETO AS
EXHIBIT A, ARE INCORPORATED HEREIN AND MADE A PART HEREOF AS IF SET
FORTH AT LENGTH HEREIN.
9. Optional Form of Payment for Shares.
Payment for any number of shares of stock of the Company purchased
pursuant to the exercise of this option may, at the election of the
Optionee, be made by delivering to the Company a number of shares of the
Common Stock of the Company, which the Optionee has owned for at least
six months, with a Fair Market Value (as defined in the Plan), on the
date this option is exercised, equal to the option exercise price for
such shares.
WILSHIRE TECHNOLOGIES, INC.
By /s/ KEVIN MULVIHILL
--------------------------------------
President & Chief Executive Officer
6
<PAGE> 7
I hereby accept the foregoing stock option on the terms and conditions
hereinabove stated.
OPTIONEE,
---------------------
(Please print or type)
Date:______________ Signature:_________________
7
<PAGE> 8
EXERCISE OF OPTION
The undersigned hereby irrevocably elects to exercise the right
to purchase _______________ shares of Common Stock of Wilshire Technologies,
Inc. (the "Shares"), such right being represented by the Stock Option granted to
me on ______________ and herewith tenders payment for the Shares to the order of
Wilshire Technologies, Inc., in the amount of $________________ (equal to [the
number of shares] multiplied by $_________ [the exercise price stated in the
Stock Option]).
The undersigned requests that a certificate for the Shares be
registered in the name of_____________, and delivered to, the undersigned at the
following address:______________________________________________________________
________________________________________________________________________________
________________________________________________________________________________
------------------------------------
(Please print or type)
Date:___________ Signature_______________________________
Social Security Number______-___-_______
8
<PAGE> 1
EXHIBIT 10.147
WILSHIRE TECHNOLOGIES, INC.
NON-QUALIFIED STOCK OPTION
1995 STOCK OPTION PLAN
THIS IS TO CERTIFY that on MAY 12, 1999, WILSHIRE TECHNOLOGIES, INC., a
California corporation (the "Company") has granted to BEN ZARZA (the "Optionee")
an option to purchase 5,000 shares of common stock of the Company, no par value,
at a price of $0.75 per share, upon the terms and conditions hereinafter stated,
to all of which the Optionee, by the acceptance hereof, assents.
1. Option Period and Conditions on Exercise.
The option shall not be exercisable with respect to any of the shares
subject to the option after MAY 12, 2009 and the option shall not be
exercisable with respect to fractional shares.
This option vests as follows:
As to 1,667 shares on MAY 12, 1999; and
As to an additional 1,666 shares on MAY 12, 1999;
As to an additional 1,666 shares on MAY 12, 2001.
1
<PAGE> 2
2. Effect of Termination of Employment/Effect of Death.
a. If the Optionee is an officer, employee or director of the
Company and ceases to be such for any reason other than death or
termination for cause, Optionee may exercise this option in
accordance with its terms only for a period of ninety days after
such cessation (but not beyond the Option Period). Any exercise
of this option after such cessation may be only to the extent of
the full number of shares the Optionee was entitled to purchase
under this option on the Date of such cessation, plus a portion
of the additional number of shares, if any, he would have become
entitled to purchase on the next anniversary Date of the Date of
grant of the option following such cessation, such portion to be
determined by multiplying such additional number of shares by a
fraction, the numerator of which is the number of days from the
anniversary Date of the Date of grant preceding such cessation
to the Date of such cessation and the denominator of which is
365. Such portion shall be rounded, if necessary, to the nearest
whole share.
b. If the termination of the Optionee's position as an officer or
employee of the Company is for cause (as determined in the sole
judgment of the Board of Directors), this option shall thereupon
be cancelled and the Optionee shall have no right to exercise
any part of this option after such termination.
c. If the Optionee dies, this option continues in effect and may be
exercised in accordance with its terms for twelve months from
the date of the Optionee's death
2
<PAGE> 3
(but not beyond the Option Period) by the executor or
administrator of the estate, or in the event there is none, then
by the person or persons to whom the optionee's rights under
this option shall pass by will or the laws of descent and
distribution. Any exercise of this option after such death may
be only to the extent of the full number of shares the optionee
was entitled to purchase under this option on the date of death,
plus a portion of the additional number of shares, if any, he
would have become entitled to purchase on the next anniversary
date of the date of grant of the option following such death,
such portion to be determined by multiplying such additional
number of shares by a fraction, the numerator of which shall be
the number of days from the anniversary Date of the Date of
grant preceding such death to the Date of death and the
denominator of which shall be 365. Such portion shall be
rounded, if necessary, to the nearest whole share.
3. Manner of Exercise.
This option shall be exercised by giving written notice to the Company
addressed in the manner specified in paragraph 7, specifying the number
of shares to be purchased and accompanied by payment in full in cash, or
in whole or in part in Common Stock, as provided in paragraph 9, for the
shares purchased.
3
<PAGE> 4
4. Nontransferability of Option.
This option shall not be transferable except to the executor or
administrator of the Optionee's estate or to the Optionee's heirs or
legatees, and shall be exercisable during the Optionee's lifetime only
by the Optionee. This option may, however, be surrendered to the Company
for cancellation for such consideration and upon such terms as may be
mutually agreed upon by the Company and the Optionee.
5. Adjustment of Shares and Price Per Share.
The number of shares subject to this option shall be adjusted as
follows:
a. In the event the Company's outstanding common stock is changed
by any stock dividend, stock split, or combination of shares,
the number of shares subject to this option shall be
proportionately adjusted, without change in the aggregate
purchase price.
b. Except as provided in subsection (d) hereof, in the event of any
merger, consolidation, or reorganization of the Company with any
other corporation or corporations, there shall be substituted on
an equitable basis, for each share of common stock then subject
to this option, an option for the number and kind of shares of
stock or other securities to which the holders of common stock
of the Company will be entitled pursuant to the transaction.
c. In the event of any other relevant change in the capitalization
of the Company, this option and the purchase price per share
shall be equitably adjusted.
d. In the event of a merger described in Section 368 (a)(2)(E) of
the Internal Revenue Code of 1986 in
4
<PAGE> 5
which the Company is the surviving corporation, this option
shall terminate and thereupon become null and void but only if
the controlling corporation shall agree to exchange its options
for this option; but the Optionee shall have the right,
immediately prior to such merger, to exercise this option,
without regard to any otherwise applicable restriction as to
time of exercise, other than expiration of the Option Period.
e. Upon the dissolution of the Company, this option shall terminate
and thereafter become null and void; but the Optionee shall have
the right, immediately prior to such dissolution, to exercise
this option without regard to any otherwise applicable
restriction as to time of exercise, other than expiration of the
Option Period.
6. Compliance with Applicable Law.
The exercise of this option is subject to the obtaining of any consent
or approval of any governmental or other regulatory body which the Board
of Directors, in its discretion, deems necessary or desirable.
7. Other Provisions.
a. The holder of this option shall not be entitled to any rights of
a shareholder of the Company with respect to any shares subject
to this option until such shares have been paid for in full and
issued to him.
b. Nothing in this Certificate shall be construed as limiting any
rights which the Company or any parent or
5
<PAGE> 6
subsidiary corporation of the Company may have to terminate at
any time the employment of the Optionee.
c. Notice to the Company hereunder shall be addressed to the
attention of its Secretary at its corporate office at 5861
Edison Place, Carlsbad, California 92008.
8. Incorporation of Plan by Reference.
EXCEPT AS MODIFIED OR AMPLIFIED BY THE SPECIFIC TERMS OF THIS AGREEMENT,
ALL OF THE TERMS AND PROVISIONS OF THE WILSHIRE TECHNOLOGIES, INC. 1995
STOCK OPTION PLAN (THE "PLAN"), A COPY OF WHICH IS ATTACHED HERETO AS
EXHIBIT A, ARE INCORPORATED HEREIN AND MADE A PART HEREOF AS IF SET
FORTH AT LENGTH HEREIN.
9. Optional Form of Payment for Shares.
Payment for any number of shares of stock of the Company purchased
pursuant to the exercise of this option may, at the election of the
Optionee, be made by delivering to the Company a number of shares of the
Common Stock of the Company, which the Optionee has owned for at least
six months, with a Fair Market Value (as defined in the Plan), on the
date this option is exercised, equal to the option exercise price for
such shares.
WILSHIRE TECHNOLOGIES, INC.
By /S/ KEVIN MULVIHILL
-----------------------------------
President & Chief Executive Officer
6
<PAGE> 7
I hereby accept the foregoing stock option on the terms and conditions
hereinabove stated.
OPTIONEE,
---------------------
(Please print or type)
Date:______________ Signature:_________________
7
<PAGE> 8
EXERCISE OF OPTION
The undersigned hereby irrevocably elects to exercise the right
to purchase _______________ shares of Common Stock of Wilshire Technologies,
Inc. (the "Shares"), such right being represented by the Stock Option granted to
me on ______________ and herewith tenders payment for the Shares to the order of
Wilshire Technologies, Inc., in the amount of $________________ (equal to [the
number of shares] multiplied by $_________ [the exercise price stated in the
Stock Option]).
The undersigned requests that a certificate for the Shares be
registered in the name of_____________, and delivered to, the undersigned at the
following address:____________________________________________________________
______________________________________________________________________________
______________________________________________________________________________
______________________________________________________________________________
------------------------------------
(Please print or type)
Date:___________ Signature_______________________________
Social Security Number______-___-_______
8
<PAGE> 1
EXHIBIT 10.148
WILSHIRE TECHNOLOGIES, INC.
NON-QUALIFIED STOCK OPTION
1995 STOCK OPTION PLAN
THIS IS TO CERTIFY that on APRIL 15, 1999, WILSHIRE TECHNOLOGIES, INC., a
California corporation (the "Company") has granted to Grace Reasoner (the
"Optionee") an option to purchase 2,500 shares of common stock of the Company,
no par value, at a price of $ 0.35 per share, upon the terms and conditions
hereinafter stated, to all of which the Optionee, by the acceptance hereof,
assents.
1. Option Period and Conditions on Exercise.
The option shall not be exercisable with respect to any of the shares
subject to the option after APRIL 15, 2009 and the option shall not be
exercisable with respect to fractional shares.
This option vests as follows:
As to 833 shares on APRIL 15, 1999; and
As to an additional 833 shares on APRIL 15, 2000;
As to an additional 834 shares on APRIL 15, 2001.
1
<PAGE> 2
2. Effect of Termination of Employment/Effect of Death.
a. If the Optionee is an officer, employee or director of the
Company and ceases to be such for any reason other than death or
termination for cause, Optionee may exercise this option in
accordance with its terms only for a period of ninety days after
such cessation (but not beyond the Option Period). Any exercise
of this option after such cessation may be only to the extent of
the full number of shares the Optionee was entitled to purchase
under this option on the Date of such cessation, plus a portion
of the additional number of shares, if any, he would have become
entitled to purchase on the next anniversary Date of the Date of
grant of the option following such cessation, such portion to be
determined by multiplying such additional number of shares by a
fraction, the numerator of which is the number of days from the
anniversary Date of the Date of grant preceding such cessation
to the Date of such cessation and the denominator of which is
365. Such portion shall be rounded, if necessary, to the nearest
whole share.
b. If the termination of the Optionee's position as an officer or
employee of the Company is for cause (as determined in the sole
judgment of the Board of Directors), this option shall thereupon
be cancelled and the Optionee shall have no right to exercise
any part of this option after such termination.
c. If the Optionee dies, this option continues in effect and may be
exercised in accordance with its terms for twelve months from
the date of the Optionee's death (but not beyond the Option
Period) by the executor or administrator of the estate, or in
the event there is none, then by the person or persons to whom
the optionee's rights under this option shall pass by will
2
<PAGE> 3
or the laws of descent and distribution. Any exercise of this
option after such death may be only to the extent of the full
number of shares the optionee was entitled to purchase under
this option on the date of death, plus a portion of the
additional number of shares, if any, he would have become
entitled to purchase on the next anniversary date of the date of
grant of the option following such death, such portion to be
determined by multiplying such additional number of shares by a
fraction, the numerator of which shall be the number of days
from the anniversary Date of the Date of grant preceding such
death to the Date of death and the denominator of which shall be
365. Such portion shall be rounded, if necessary, to the nearest
whole share.
3. Manner of Exercise.
This option shall be exercised by giving written notice to the Company
addressed in the manner specified in paragraph 7, specifying the number
of shares to be purchased and accompanied by payment in full in cash, or
in whole or in part in Common Stock, as provided in paragraph 9, for the
shares purchased.
3
<PAGE> 4
4. Nontransferability of Option.
This option shall not be transferable except to the executor or
administrator of the Optionee's estate or to the Optionee's heirs or
legatees, and shall be exercisable during the Optionee's lifetime only
by the Optionee. This option may, however, be surrendered to the Company
for cancellation for such consideration and upon such terms as may be
mutually agreed upon by the Company and the Optionee.
5. Adjustment of Shares and Price Per Share.
The number of shares subject to this option shall be adjusted as
follows:
a. In the event the Company's outstanding common stock is changed
by any stock dividend, stock split, or combination of shares,
the number of shares subject to this option shall be
proportionately adjusted, without change in the aggregate
purchase price.
b. Except as provided in subsection (d) hereof, in the event of any
merger, consolidation, or reorganization of the Company with any
other corporation or corporations, there shall be substituted on
an equitable basis, for each share of common stock then subject
to this option, an option for the number and kind of shares of
stock or other securities to which the holders of common stock
of the Company will be entitled pursuant to the transaction.
c. In the event of any other relevant change in the capitalization
of the Company, this option and the purchase price per share
shall be equitably adjusted.
d. In the event of a merger described in Section 368 (a)(2)(E) of
the Internal Revenue Code of 1986 in which the Company is the
surviving corporation, this option shall terminate and thereupon
become null and void but only if the controlling corporation
shall agree to exchange its options for this option; but the
4
<PAGE> 5
Optionee shall have the right, immediately prior to such merger,
to exercise this option, without regard to any otherwise
applicable restriction as to time of exercise, other than
expiration of the Option Period.
e. Upon the dissolution of the Company, this option shall terminate
and thereafter become null and void; but the Optionee shall have
the right, immediately prior to such dissolution, to exercise
this option without regard to any otherwise applicable
restriction as to time of exercise, other than expiration of the
Option Period.
6. Compliance with Applicable Law.
The exercise of this option is subject to the obtaining of any consent
or approval of any governmental or other regulatory body which the Board
of Directors, in its discretion, deems necessary or desirable.
7. Other Provisions.
a. The holder of this option shall not be entitled to any rights of
a shareholder of the Company with respect to any shares subject
to this option until such shares have been paid for in full and
issued to him.
b. Nothing in this Certificate shall be construed as limiting any
rights which the Company or any parent or subsidiary corporation
of the Company may have to terminate at any time the employment
of the Optionee.
c. Notice to the Company hereunder shall be addressed to the
attention of its Secretary at its corporate office at 5861
Edison Place, Carlsbad, California 92008.
8. Incorporation of Plan by Reference.
5
<PAGE> 6
EXCEPT AS MODIFIED OR AMPLIFIED BY THE SPECIFIC TERMS OF THIS AGREEMENT,
ALL OF THE TERMS AND PROVISIONS OF THE WILSHIRE TECHNOLOGIES, INC. 1995
STOCK OPTION PLAN (THE "PLAN"), A COPY OF WHICH IS ATTACHED HERETO AS
EXHIBIT A, ARE INCORPORATED HEREIN AND MADE A PART HEREOF AS IF SET
FORTH AT LENGTH HEREIN.
9. Optional Form of Payment for Shares.
Payment for any number of shares of stock of the Company purchased
pursuant to the exercise of this option may, at the election of the
Optionee, be made by delivering to the Company a number of shares of the
Common Stock of the Company, which the Optionee has owned for at least
six months, with a Fair Market Value (as defined in the Plan), on the
date this option is exercised, equal to the option exercise price for
such shares.
WILSHIRE TECHNOLOGIES, INC.
By /s/ Kevin T. Mulvihill
---------------------------------
President & Chief Executive
Officer
6
<PAGE> 7
I hereby accept the foregoing stock option on the terms and conditions
hereinabove stated.
OPTIONEE,
---------------------
(Please print or type)
Date: Signature:
-------------- -----------------
7
<PAGE> 8
EXERCISE OF OPTION
The undersigned hereby irrevocably elects to exercise the right to
purchase _______________ shares of Common Stock of Wilshire Technologies, Inc.
(the "Shares"), such right being represented by the Stock Option granted to me
on ______________ and herewith tenders payment for the Shares to the order of
Wilshire Technologies, Inc., in the amount of $________________ (equal to [the
number of shares] multiplied by $_________ [the exercise price stated in the
Stock Option]).
The undersigned requests that a certificate for the Shares be registered
in the of_____________, and delivered to, the undersigned at the following
address: _______________________________________________________________________
________________________________________________________________________________
________________________________________________________________________________
________________________________________________________________________________
-----------------------------------
(Please print or type)
Date: Signature:
-------------- -----------------
Social Security Number______-___-_______
------ --- -------
8
<TABLE> <S> <C>
<ARTICLE> 5
<MULTIPLIER> 1,000
<S> <C>
<PERIOD-TYPE> 6-MOS
<FISCAL-YEAR-END> NOV-30-1999
<PERIOD-START> DEC-01-1998
<PERIOD-END> MAY-13-1999
<CASH> 115
<SECURITIES> 0
<RECEIVABLES> 355
<ALLOWANCES> 7
<INVENTORY> 1,412
<CURRENT-ASSETS> 2,201
<PP&E> 3,690
<DEPRECIATION> 386
<TOTAL-ASSETS> 6,366
<CURRENT-LIABILITIES> 12,086
<BONDS> 0
0
0
<COMMON> 25,912
<OTHER-SE> (32,019)
<TOTAL-LIABILITY-AND-EQUITY> 6,366
<SALES> 1,443
<TOTAL-REVENUES> 1,443
<CGS> 1,511
<TOTAL-COSTS> 1,511
<OTHER-EXPENSES> 1,301
<LOSS-PROVISION> 0
<INTEREST-EXPENSE> 575
<INCOME-PRETAX> (1,939)
<INCOME-TAX> 1
<INCOME-CONTINUING> (1,940)
<DISCONTINUED> 0
<EXTRAORDINARY> 0
<CHANGES> 0
<NET-INCOME> (1,940)
<EPS-BASIC> (.15)
<EPS-DILUTED> (.15)
</TABLE>
